glp 1 kidney stones Certain diabetes drugs linked to lower risk of and gout Kidney Stones: Types, Causes, Risk
Description
Revenue in the GLP-1 market is projected to exceed $100 billion annually by 2030
Diabetes Metab Res Rev (2016) 32:77690
doi: 10.1161/CIRCULATIONAHA.117.028136
doi: 10.1016/j.molmet.2025.102235
2022a;33(5):36478
Maximum efficacy for liraglutide occurs around week 40-56, while tirzepatide continues producing weight loss through week 72
